Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy

AIM: To examine cytokeratin-18 (CK-18) and caspase-cleaved CK-18 expression in tumours and correlate with clinicopathological outcomes including tumour regression grade (TRG) response. METHODS: Formalin-fixed human gastro-oesophageal cancers were constructed into tissue microarrays. The first set...

Full description

Bibliographic Details
Main Authors: Fareed, Khaleel R., Soomro, Irshad N., Hameed, Khalid, Arora, Arvind, Lobo, Dileep N., Parsons, Simon L., Madhusudan, Srinivasan
Format: Article
Published: Baishideng Publishing Group 2012
Online Access:https://eprints.nottingham.ac.uk/2797/
_version_ 1848790878146002944
author Fareed, Khaleel R.
Soomro, Irshad N.
Hameed, Khalid
Arora, Arvind
Lobo, Dileep N.
Parsons, Simon L.
Madhusudan, Srinivasan
author_facet Fareed, Khaleel R.
Soomro, Irshad N.
Hameed, Khalid
Arora, Arvind
Lobo, Dileep N.
Parsons, Simon L.
Madhusudan, Srinivasan
author_sort Fareed, Khaleel R.
building Nottingham Research Data Repository
collection Online Access
description AIM: To examine cytokeratin-18 (CK-18) and caspase-cleaved CK-18 expression in tumours and correlate with clinicopathological outcomes including tumour regression grade (TRG) response. METHODS: Formalin-fixed human gastro-oesophageal cancers were constructed into tissue microarrays. The first set consisted of 122 gastric/gastro-oesophageal cancer cases not exposed to neoadjuvant chemotherapy and the second set consisted of 97 gastric/gastro-oesophageal cancer cases exposed to pre-operative platinum-based chemotherapy. Expression of CK-18 and caspase-cleaved CK-18 was investigated using immunohistochemistry. RESULTS: CK18 was commonly expressed in gastro-oesophageal tumours (92.6%). Fifty-six point seven percent of tumours previously exposed to neoadjuvant chemotherapy were positive for caspase-cleaved CK-18 expression compared to only 24.6% of tumours not previously exposed to neoadjuvant chemotherapy (P = 0.009). In patients who received neoadjuvant chemotherapy, caspase-cleaved cytokeratin-18 expression correlated with favourable TRG response (TRG 1, 2 or 3, P = 0.043). CONCLUSION: This is the largest study to date of CK-18 and caspase-cleaved CK-18 expression in gastro-oesophageal tumours. We provide the first evidence that caspase-cleaved CK-18 predicts tumour regression with neoadjuvant chemotherapy.
first_indexed 2025-11-14T18:19:36Z
format Article
id nottingham-2797
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T18:19:36Z
publishDate 2012
publisher Baishideng Publishing Group
recordtype eprints
repository_type Digital Repository
spelling nottingham-27972020-05-04T16:32:53Z https://eprints.nottingham.ac.uk/2797/ Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy Fareed, Khaleel R. Soomro, Irshad N. Hameed, Khalid Arora, Arvind Lobo, Dileep N. Parsons, Simon L. Madhusudan, Srinivasan AIM: To examine cytokeratin-18 (CK-18) and caspase-cleaved CK-18 expression in tumours and correlate with clinicopathological outcomes including tumour regression grade (TRG) response. METHODS: Formalin-fixed human gastro-oesophageal cancers were constructed into tissue microarrays. The first set consisted of 122 gastric/gastro-oesophageal cancer cases not exposed to neoadjuvant chemotherapy and the second set consisted of 97 gastric/gastro-oesophageal cancer cases exposed to pre-operative platinum-based chemotherapy. Expression of CK-18 and caspase-cleaved CK-18 was investigated using immunohistochemistry. RESULTS: CK18 was commonly expressed in gastro-oesophageal tumours (92.6%). Fifty-six point seven percent of tumours previously exposed to neoadjuvant chemotherapy were positive for caspase-cleaved CK-18 expression compared to only 24.6% of tumours not previously exposed to neoadjuvant chemotherapy (P = 0.009). In patients who received neoadjuvant chemotherapy, caspase-cleaved cytokeratin-18 expression correlated with favourable TRG response (TRG 1, 2 or 3, P = 0.043). CONCLUSION: This is the largest study to date of CK-18 and caspase-cleaved CK-18 expression in gastro-oesophageal tumours. We provide the first evidence that caspase-cleaved CK-18 predicts tumour regression with neoadjuvant chemotherapy. Baishideng Publishing Group 2012-04-28 Article PeerReviewed Fareed, Khaleel R., Soomro, Irshad N., Hameed, Khalid, Arora, Arvind, Lobo, Dileep N., Parsons, Simon L. and Madhusudan, Srinivasan (2012) Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy. World Journal of Gastroenterology, 18 (16). pp. 1915-1920. ISSN 1007-9327 http://www.wjgnet.com/1007-9327/abstract/v18/i16/1915.htm doi:10.3748/wjg.v18.i16.1915 doi:10.3748/wjg.v18.i16.1915
spellingShingle Fareed, Khaleel R.
Soomro, Irshad N.
Hameed, Khalid
Arora, Arvind
Lobo, Dileep N.
Parsons, Simon L.
Madhusudan, Srinivasan
Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy
title Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy
title_full Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy
title_fullStr Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy
title_full_unstemmed Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy
title_short Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy
title_sort caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy
url https://eprints.nottingham.ac.uk/2797/
https://eprints.nottingham.ac.uk/2797/
https://eprints.nottingham.ac.uk/2797/